(Q34653765)

3 August 2017

Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines (English)

1 reference

ESMO Guidelines Working Group

3 August 2017

1 reference

D Arnold

4

0 references

Judith Balmaña

object named as

J Balmaña

series ordinal

1

0 references

series ordinal

5

object named as

ESMO Guidelines Working Group

1 reference

3 August 2017

F Balaguer

2

1 reference

PubMed ID

23813931

3 August 2017

A Cervantes

series ordinal

3

1 reference

3 August 2017

27 June 2013

1 reference

3 August 2017

1 reference

3 August 2017

24 Suppl 6

1 reference

3 August 2017

vi73-80

1 reference

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

3 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Identification of Lynch syndrome among patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Inheritance of a Cancer-AssociatedMLH1Germ-Line Epimutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Systematic review of microsatellite instability and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Extra-intestinal manifestations of familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Guidelines for the clinical management of familial adenomatous polyposis (FAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Duodenal adenomatosis in familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Prevention and management of duodenal polyps in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT209

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT209

1 reference

3 August 2017

1 reference

PubMed ID

23813931